Ultragenyx Pharmaceutical Inc. 8-K Report: Key Developments Unveiled
Based on the provided section of the financial report, here are the key insights extracted:
- Entity Information:
- Name: Ultragenyx Pharmaceutical Inc.
- CIK Number: 0001515673
- IRS Employer Identification Number (EIN): 27-2546083
- Address: 60 Leveroni Court, Novato, CA 94949
- Phone Number: 415-483-8800
- Report Type:
- Form: 8-K (This form is used to report major events that shareholders should know about.)
- Filing Date:
- Date of Filing: December 19, 2024
- Security Information:
- Common Stock: $0.001 par value
- Ticker Symbol: RARE
- Exchange: NASDAQ
- Period Covered:
- This filing pertains to a specific date: December 19, 2024.
Summary:
Ultragenyx Pharmaceutical Inc. filed an 8-K report on December 19, 2024, with the SEC. The company is publicly traded on NASDAQ under the ticker RARE, with common stock having a par value of $0.001. The report likely contains significant developments or events affecting the company that are relevant to investors and stakeholders.